Home › Companies › Haemonetics Corporation › 2025-2026

Haemonetics Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Haemonetics Corporation’s Form 8-K, filed 2025-07-25 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 11Ballot items
  • 342Asset managers
  • 4,113Fund votes
  • 2025-07-24Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Haemonetics Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Haemonetics Corporation

These tallies are Haemonetics Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-07-25 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Haemonetics Corporation — official shareholder meeting results, meeting held 2025-07-24
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Christopher A. Simon 43,756,151---- 99,1661,757,724 Majority: yes
Elect Director: Robert E. Abernathy 43,061,317---- 794,0001,757,724 Majority: yes
Elect Director: Diane M. Bryant 43,568,258---- 287,0591,757,724 Majority: yes
Elect Director: Michael J. Coyle 43,670,835---- 184,4821,757,724 Majority: yes
Elect Director: Charles J. Dockendorff 42,588,774---- 1,266,5431,757,724 Majority: yes
Elect Director: Lloyd E. Johnson 43,151,041---- 704,2761,757,724 Majority: yes
Elect Director: Mark W. Kroll 42,739,455---- 1,115,8621,757,724 Majority: yes
Elect Director: Claire Pomeroy 43,567,795---- 287,5221,757,724 Majority: yes
Elect Director: Ellen M. Zane 43,066,065---- 789,2521,757,724 Majority: yes
Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes: 43,016,961585,626252,730 --1,757,724 Majority: yes
Proposal 3: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 28, 2026 based upon the following votes: 43,843,3961,525,114244,531 ---- Majority: yes

Source: Haemonetics Corporation, Form 8-K, filed with the SEC on 2025-07-25 — read the filing on EDGAR.

How asset managers voted at the Haemonetics Corporation 2025-2026 meeting

Each item below shows how the 342 asset managers that disclosed a Haemonetics Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 43,016,961AGAINST: 585,626

Haemonetics Corporation’s own tally for this item (“Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”): 43,016,961 for, 585,626 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 1% against (85% of the company cast a for/against vote).

The 334 asset managers below cast 99.0% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 99%
FOR: 98.6%AGAINST: 0.9%ABSTAIN: 0.5%NOT VOTED: 0.0%
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Neuberger Berman6,626,078700 00For
Vanguard6,425,368426 00For
BlackRock5,478,895209 00For
T. Rowe Price3,145,7540 00For
Fidelity2,773,6370 00For
Allspring1,760,0770 00For
Wellington1,685,1140 00For
State Street1,638,921539 00For
River Road Asset Management, LLC1,360,8300 00For
GEODE CAPITAL MANAGEMENT, LLC1,235,7650 00For
Royce1,158,3760 00For
Capital Group1,139,0430 00For
Capital Research Global Investors1,139,0430 00For
Charles Schwab1,114,0600 00For
John Hancock888,8300 00For
FRANKLIN ADVISERS INC581,3340 00For
SILVERCREST ASSET MANAGEMENT GROUP LLC548,45716,570 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
Dimensional474,5860 00For
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/462,5670 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
Northern Trust444,4990 00For
Boston Partners432,4110 00For
BOSTON TRUST WALDEN NATIONAL ASSOCIATION431,7270 00For
Fisher Asset Management, LLC422,9450 00For

Showing the 25 largest of 334 asset managers. See all 334 in the interactive database.

2. Election of Directors: Charles J. Dockendorff

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 42,588,774WITHHELD: 1,266,543

Haemonetics Corporation’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 42,588,774 for, 1,266,543 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 83% for, 2% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (24,948,823 for, 0 against).

FOR 99.4%
FOR: 24,948,823 (99.4%)ABSTAIN: 140,012 (0.6%)
Largest asset managers voting on “Election of Directors: Charles J. Dockendorff” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9300 300For
Bridge Builder Trust158,8710 101,7660For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

3. Election of Directors: Christopher A. Simon

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 43,756,151WITHHELD: 99,166

Haemonetics Corporation’s own tally for this item (“Elect Director: Christopher A. Simon”): 43,756,151 for, 99,166 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 86% for, 0.2% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (25,074,889 for, 0 against).

FOR 99.9%
FOR: 25,074,889 (99.9%)ABSTAIN: 13,946 (0.1%)
Largest asset managers voting on “Election of Directors: Christopher A. Simon” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

4. Election of Directors: Claire Pomeroy

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 43,567,795WITHHELD: 287,522

Haemonetics Corporation’s own tally for this item (“Elect Director: Claire Pomeroy”): 43,567,795 for, 287,522 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 85% for, 0.6% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (25,065,967 for, 0 against).

FOR 99.9%
FOR: 25,065,967 (99.9%)ABSTAIN: 22,868 (0.1%)
Largest asset managers voting on “Election of Directors: Claire Pomeroy” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

5. Election of Directors: Diane M. Bryant

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 43,568,258WITHHELD: 287,059

Haemonetics Corporation’s own tally for this item (“Elect Director: Diane M. Bryant”): 43,568,258 for, 287,059 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 85% for, 0.6% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (25,065,967 for, 0 against).

FOR 99.9%
FOR: 25,065,967 (99.9%)ABSTAIN: 22,868 (0.1%)
Largest asset managers voting on “Election of Directors: Diane M. Bryant” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

6. Election of Directors: Ellen M. Zane

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 43,066,065WITHHELD: 789,252

Haemonetics Corporation’s own tally for this item (“Elect Director: Ellen M. Zane”): 43,066,065 for, 789,252 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (25,049,020 for, 0 against).

FOR 99.8%
FOR: 25,049,020 (99.8%)ABSTAIN: 39,815 (0.2%)
Largest asset managers voting on “Election of Directors: Ellen M. Zane” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,4910 4230For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

7. Election of Directors: Lloyd E. Johnson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 43,151,041WITHHELD: 704,276

Haemonetics Corporation’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 43,151,041 for, 704,276 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 1% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (25,057,440 for, 0 against).

FOR 99.8%
FOR: 25,057,440 (99.9%)ABSTAIN: 31,395 (0.1%)
Largest asset managers voting on “Election of Directors: Lloyd E. Johnson” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

8. Election of Directors: Mark W. Kroll

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 42,739,455WITHHELD: 1,115,862

Haemonetics Corporation’s own tally for this item (“Elect Director: Mark W. Kroll”): 42,739,455 for, 1,115,862 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (24,963,737 for, 0 against).

FOR 99.5%
FOR: 24,963,737 (99.5%)ABSTAIN: 125,098 (0.5%)
Largest asset managers voting on “Election of Directors: Mark W. Kroll” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9300 300For
Bridge Builder Trust158,8710 101,7660For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

9. Election of Directors: Michael J. Coyle

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 43,670,835WITHHELD: 184,482

Haemonetics Corporation’s own tally for this item (“Elect Director: Michael J. Coyle”): 43,670,835 for, 184,482 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 85% for, 0.4% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (25,074,889 for, 0 against).

FOR 99.9%
FOR: 25,074,889 (99.9%)ABSTAIN: 13,946 (0.1%)
Largest asset managers voting on “Election of Directors: Michael J. Coyle” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

10. Election of Directors: Robert E. Abernathy

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 43,061,317WITHHELD: 794,000

Haemonetics Corporation’s own tally for this item (“Elect Director: Robert E. Abernathy”): 43,061,317 for, 794,000 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (25,051,053 for, 0 against).

FOR 99.8%
FOR: 25,051,053 (99.8%)ABSTAIN: 37,782 (0.2%)
Largest asset managers voting on “Election of Directors: Robert E. Abernathy” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,9140 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,9600 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

11. To Ratify The Appointment Of Ernst & Young Llp As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending March 28, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 43,843,396AGAINST: 1,525,114

Haemonetics Corporation’s own tally for this item (“Proposal 3: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 28, 2026 based upon the following votes:”): 43,843,396 for, 1,525,114 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 86% for, 3% against (89% of the company cast a for/against vote).

The 101 asset managers below cast 99.9% of the shares they voted on this item FOR (25,065,514 for, 9,375 against).

FOR 99.9%
FOR: 25,065,514 (99.9%)AGAINST: 9,375 (0.0%)ABSTAIN: 13,946 (0.1%)
Largest asset managers voting on “To Ratify The Appointment Of Ernst & Young Llp As Our Independent Registered Public Accounting Firm For The Fi” at Haemonetics Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard6,176,491423 00For
BlackRock3,505,8640 00For
Neuberger Berman2,474,9210 00For
Fidelity1,954,4160 00For
Capital Group1,139,0430 00For
Royce952,2490 00For
T. Rowe Price860,1610 00For
Allspring772,6200 00For
Charles Schwab557,0020 00For
FRANKLIN STRATEGIC SERIES529,2000 00For
BOSTON TRUST WALDEN FUNDS450,9350 00For
John Hancock439,6360 00For
Brighthouse399,3850 13,9460For
TOUCHSTONE STRATEGIC TRUST411,5900 00For
AMG Funds IV376,4120 00For
SCHWARTZ INVESTMENT TRUST372,5000 00For
Dimensional363,3900 00For
State Street358,93030 00For
Bridge Builder Trust260,6370 00For
Jackson National200,9390 00For
Equitable172,4420 00For
WILLIAM BLAIR FUNDS154,0100 00For
HEARTLAND GROUP INC140,0000 00For
Empower121,7310 00For
TIAA107,9030 00For

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

Largest Haemonetics Corporation shareholders voting in 2025-2026

Ranked by the number of Haemonetics Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 51,152,886 shares outstanding at the time of that meeting.

Top Haemonetics Corporation shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Neuberger Berman 12.95%
2Vanguard 12.56%
3BlackRock 10.71%
4T. Rowe Price 6.15%
5Fidelity 5.42%
6Allspring 3.44%
7Wellington 3.29%
8State Street 3.21%
9River Road Asset Management, LLC 2.66%
10GEODE CAPITAL MANAGEMENT, LLC 2.42%

Reported Haemonetics Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Haemonetics Corporation beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 10.99% 13F
Neuberger Berman Group LLC 6.90% DEF14A
AQR Capital Management LLC 6.18% DEF14A
Vanguard Portfolio Management LLC 5.08% DEF14A
Vanguard Capital Management 4.78% 13G
State Street 3.47% 13F
Dimensional Fund Advisors 2.59% 13F
FMR (Fidelity) 2.49% 13F
Geode Capital 2.38% 13F
Goldman Sachs 1.89% 13F

Percentages above are of 51,152,886 shares outstanding, as reported by Haemonetics Corporation on its Form 10-Q dated 2024-06-29 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Haemonetics Corporation’s 10-Q dated 2024-06-29. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Haemonetics Corporation's shareholder meeting held 2025-07-24, in the 2025-2026 proxy season, 342 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 4,113 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Haemonetics Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-07-25.

Haemonetics Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).